YAN Quanxiang, FENG Li, XU Feng, et al. Thrombolytic Effect of Nattokinase and Its Mechanism[J]. Science and Technology of Food Industry, 2021, 42(24): 340−346. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021030178.
Citation: YAN Quanxiang, FENG Li, XU Feng, et al. Thrombolytic Effect of Nattokinase and Its Mechanism[J]. Science and Technology of Food Industry, 2021, 42(24): 340−346. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021030178.

Thrombolytic Effect of Nattokinase and Its Mechanism

More Information
  • Received Date: March 14, 2021
  • Available Online: October 20, 2021
  • Objective: Exploring the anti-thrombotic effect and mechanism of nattokinase(NK) in vitro and vivo. Methods: The thrombolytic effect of NK on old thrombus was studied by blood clot lysis method in vitro, the rat carotid artery thrombosis model induced by ferric chloride and the rat venous thrombosis model induced by inferior vena cava ligation method were used to study the thrombolytic effect of NK in vivo. Thromboxane(TXB2), 6-keto-prostaglandin F1α(6-K-PGF1α), prostaglandin E2(PGE2), tissue type plasminogenactivator(t-PA), O2, ·OH, xanthine oxidase(XOD) and other indicators were detected to explore the antithrombotic mechanism of NK. Results: Nattokinase could significantly dissolve old thrombus (P<0.05) in vitro, and had a strong thrombolytic effect in vivo, and its thrombolytic effect was stronger than that of urokinase. Nattokinase could significantly affect the values of TXB2, 6-K-PGF1α, PGE2, t-PA, O2, ·OH and XOD. The values of TXB2, PEG2, O2, ·OH and XOD increased significantly(P<0.05) , while the values of 6-K-PGF1α and t-PA decreased significantly(P<0.05) . Conclusion : NK had strong thrombolytic activity in vivo and vitro, and had effect on fresh thrombus and old thrombus. NK could inhibit thrombosis by inhibiting platelet aggregation, reducing oxidative damage and reducing the level of coagulation factors. NK could also play a direct thrombolytic role by stimulating the production of t-PA, dissolving fibrin, and might play an indirect thrombolytic role by inhibiting the production of plasminogen activator inhibitor 1(PAI-1).
  • [1]
    WANG Y, GAO H, C W KESSINGER, et al. Myeloid-related protein-14 regulates deep vein thrombosis[J]. Jci Insight,2017,2(11):1−12.
    [2]
    刘泽霖, 贺石林, 李家增. 血栓性疾病的诊断与治疗[M]. 北京: 人民卫生出版社, 2006: 115−116.

    LIU Z L, HE S L, LI J Z. Diagnosis and treatment of thrombotic diseases[M]. Beijing: People’s Medical Publishing House, 2006: 115−116.
    [3]
    WANG W, JIANG B, SUN H, et al. Prevalence, incidence, and mortality of stroke in China[J]. Circulation,2017,35(13):759−771.
    [4]
    WU Y, BENJAMIN E J, MACMAHON S. Prevention and control of cardiovascular disease in the rapidly changing economy of China[J]. Circulation,2016,133(24):2545−2560. doi: 10.1161/CIRCULATIONAHA.115.008728
    [5]
    王春霞. 抗血栓药物研究进展[J]. 当代临床医刊,2012,25(5):86−88. [WANG C X. Research progress of antithrombotic drugs[J]. The Medical Journal of Industrial Enterprise,2012,25(5):86−88.
    [6]
    VAN GIJN J, ALGRA A. Secondary stroke prevention with antithrombotic drugs[J]. Current Vascular Pharmacology,2010,7(Suppl.6):30−32.
    [7]
    陈志文, 徐尔尼, 肖美燕. 纳豆激酶的研究进展[J]. 食品科学,2002,23(10):130−134. [CHEN Z W, XU E N, XIAO M Y. Research progress of nattokinase[J]. Food Science,2002,23(10):130−134. doi: 10.3321/j.issn:1002-6630.2002.10.036
    [8]
    SUMI H, HAMADA H, NAKANISHI K, et al. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase[J]. Acta Haematologica,1990,84(3):139−143. doi: 10.1159/000205051
    [9]
    YASUHIDE, YANAGISAWA, TOSHIYUKI, et al. Purification, crystallization and preliminary X-ray diffraction experiment of nattokinase from Bacillus subtilis natto[J]. Acta Crystallographica,2010,F66:1670−1673.
    [10]
    胡升, 梅乐和, 姚善泾. 响应面法优化纳豆激酶液体发酵[J]. 食品与发酵工业,2003,29(1):13−17. [HU S, MEI L H, YAO S J. Optimization of submerged fermentation of nattokinase production by Bacillus subtilis with response surface methodology[J]. Food and Fermentation Industries,2003,29(1):13−17. doi: 10.3321/j.issn:0253-990X.2003.01.004
    [11]
    朱健辉, 杜连祥, 路福平, 等. 高效溶栓酶-纳豆激酶的纯化及酶学性质研究[J]. 微生物学通报,2006(1):68−71. [ZHU J H, DU L X, LU F P, et al. Purification and characterization of a strong fibrinolytic enzyme-nattok inase[J]. Microbiology China,2006(1):68−71. doi: 10.3969/j.issn.0253-2654.2006.01.014
    [12]
    王俊菊, 李培锋, 关红. 纳豆激酶抗凝血作用的研究[J]. 中国生化药物杂志,2004,25(5):276−278. [WANG J J, LI P F, GUAN H. Anticoagulant effecs of nattokinase in rats[J]. Chinese Journal of Biochemical Pharmaceutics,2004,25(5):276−278. doi: 10.3969/j.issn.1005-1678.2004.05.007
    [13]
    周伏忠, 贾蕴莉, 陈国参, 等. 纳豆激酶体外溶栓效果的初步观察[J]. 食品科技,2008,33(6):249−253. [ZHOU F Z, JIA Y L, CHEN G S, et al. A priliminary study of nattokinase thrombolysis effect in vitro[J]. Food Science and Technology,2008,33(6):249−253. doi: 10.3969/j.issn.1005-9989.2008.06.077
    [14]
    吴少琴, 季乃军, 蓝翔. 永久性心房颤动患者血清TXB2、6-K-PGF1α和PGE2改变的探讨[J]. 放射免疫学杂志,2013,26(5):549−551. [WU S Q, JI N J, LAN X. Exploration the change of thromboxane B2, 6-keto-PGF1α and prostaglandin E2 in permanent atrial fibrillation patients[J]. Journal of Radioimmunology,2013,26(5):549−551. doi: 10.3969/j.issn.1008-9810.2013.05.003
    [15]
    宋秀风. 银悄病和湿疹患者体内花生四烯酸代谢产物水平检测[D]. 济南: 山东大学, 2011.

    SONG X F. A study of arachidonic acid metabolites in proriasis and eczema[D]. Jinan: Shandong University, 2011.
    [16]
    HUBBARD G P, S WOLFFRAM, J A LOVEGROVE, et al. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans[J]. Journal of Thrombosis & Haemostasis,2010,2(12):2138−2145.
    [17]
    KUROSAWA Y, NIRENGI S, HOMMA T, et al. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles[J]. Scientific Reports,2015,5:11601. doi: 10.1038/srep11601
    [18]
    张润玲, 刘玉梅, 潘云燕, 等. 脑血栓前期血管内皮细胞损伤研究[J]. 国际检验医学杂志,2005,26(7):1−3. [ZHANG R L, LIU Y M, PAN Y Y, et al. A study on the damage of endotheliocyte in prethrombotic state with brain[J]. International Journal of Laboratory Medicine,2005,26(7):1−3.
    [19]
    顾炜, 马贤德, 全连峰, 等. 特丁基对苯二酚抑制中波紫外线诱发HaCaT细胞氧化损伤[J]. 中国医科大学学报,2016(4):337−339. [GU W, MA X D, QUAN L F, et al. Tert-butylhydroquinone protects HaCaT cells from ultraviolet B-induced oxidative damages[J]. Journal of China Medical University,2016(4):337−339. doi: 10.12007/j.issn.0258-4646.2016.04.012
    [20]
    甘晓, 应燕萍. 氧化应激与血栓性疾病关系的研究进展[J]. 临床心血管病杂志,2019,35(8):758−762. [GAN X, YING Y P. Research progress in the relationship between oxidative stress and thrombotic diseases[J]. Journal of Clinical Cardiology,2019,35(8):758−762.
    [21]
    张洁. 氧化应激在高原动脉粥样硬化发生发展中的作用机制[J]. 中国民族医药杂志,2016,22(9):64−67. [ZHANG J. Mechanism of oxidative stress in the occurrence and development of atherosclerosis at high altitude[J]. Journal of Medicine and Pharmacy of Chinese Minorities,2016,22(9):64−67. doi: 10.3969/j.issn.1006-6810.2016.09.039
    [22]
    李德卫, 赵渝, 时德, 等. 下肢血栓闭塞性脉管炎患者腰交感神经节的病理变化[J]. 医学争鸣,2003,24(24):2251−2254. [LI D W, ZHAO Y, SHI D, et al. Pathological changes of lumbar sympathetic ganglia in patients with lower extremity thromboangiitis obliterans[J]. Journal of the Fourth Military Medical University,2003,24(24):2251−2254.
    [23]
    李延广. 阵发性心房颤动对内皮功能的影响研究[J]. 中华老年心脑血管病杂志,2015,17(12):1253−1256. [LI Y G. Effect of paroxysmal atrial fibrillation on endothelial function[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases,2015,17(12):1253−1256. doi: 10.3969/j.issn.1009-0126.2015.12.007
    [24]
    IWAI K, NAKAYA N, KAWASAKI Y, et al. Antioxidative functions of natto, a kind of fermented soybeans: Effect on LDL oxidation and lipid metabolism in cholesterol-fed rats[J]. Journal of Agricultural & Food Chemistry,2002,50(12):3597−3601.
    [25]
    CHANG C H, CHEN K T, LEE T H, et al. Effects of natto extract on endothelial injury in a rat model[J]. Acta Medica Okayama,2010,64(6):399−406.
    [26]
    李健. 纤维蛋白相关标志物在诊断和预防中的联合应用[J]. 中华检验医学杂志,2014,37(3):233−235. [LI J. Combined application of fibrin related markers in diagnosis and prevention[J]. Chinese Journal of Laboratory Medicine,2014,37(3):233−235.
    [27]
    XU J, DU M, YANG X, et al. Thrombolytic effects in vivo of nattokinase in a carrageenan-induced rat model of thrombosis[J]. Acta Haematologica,2014,132(2):247−253. doi: 10.1159/000360360
    [28]
    SUMI, HAMADA H, TSUSHIMA H, et al. A novel fibrinolytic enzyme(nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet[J]. Experientia,1987,43(10):1110−1111. doi: 10.1007/BF01956052
    [29]
    FUJITA M, HONG K, ITO Y, et al. Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat[J]. Biological & Pharmaceutical Bulletin,1995,18(10):1387−1391.
    [30]
    于淑红, 邢美玲. t-PA与血栓性疾病的相关性研究[J]. 中国误诊学杂志,2006,6(12):2322−2323. [YU S H, XING M L. Correlation between t-PA and thrombotic diseases[J]. Chinese Journal of Misdiagnostics,2006,6(12):2322−2323. doi: 10.3969/j.issn.1009-6647.2006.12.067
    [31]
    陈丽娟, 沙长青, 任永春, 等. 纳豆激酶溶解血栓机制[J]. 中国生物工程杂志, 2003, 23(4): 53−56, 61.

    CHEN L J, SHA CQ, REN Y C, et al. Advances in research on thrombolysis mechanism of nattokinase[J]. China Biotechnology, 2003, 23(4): 53−56, 61.
    [32]
    韩玮, 於四军, 罗建平, 等. 急性冠脉综合征患者血清SCD40 L, Periostin, IMA, PAI-1水平改变以及心功能的研究[J]. 临床和实验医学杂志,2016,15(14):1377−1380. [HAN W, YU S J, LUO J P, et al. Changes of serum SCD40L, periostin, IMA, PAI-1 levels and cardiac function in patients with acute coronary syndrome[J]. Journal of Clinical and Experimental Medicine,2016,15(14):1377−1380. doi: 10.3969/j.issn.1671-4695.2016.14.010
    [33]
    AMIN K, ZENG X B, YING Y, et al. Effect of pulsed electric fields(PEF) on protease and antioxidant activity of selenium modified fibrinolytic enzyme nattokinase produced by Bacillus natto cells[J]. International Journal of Biosciences,2019,14(5):282−293.
    [34]
    KATSUTANI M, ITO T, MASAKI T, et al. Glucose-based PD solution, but not icodextrin-based pd solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2[J]. Therapeutic Apheresis and Dialysis,2007,11(2):94−100. doi: 10.1111/j.1744-9987.2007.00423.x
    [35]
    HASSANNEJAD S, RAZEGHIAN E, SHOJAEI N. Relationship between PAI1 promoter 4G/5g polymorphism and stroke[J]. Personalized Medicine,2020,5(17):18−20.
  • Cited by

    Periodical cited type(8)

    1. 滕薇,刘树滔,吴金鸿,张勇. 透明质酸的制备、功能特性及其调节肠道健康的研究进展. 中国食品学报. 2024(07): 401-413 .
    2. 廖曦,刘雨薇,冯金华,李卡. 透明质酸水凝胶在医用导管表面改性的应用进展. 中国医疗器械杂志. 2023(02): 173-177 .
    3. 张泽华,刘志林,陈晨. 超小分子透明质酸功效性能测试. 日用化学品科学. 2023(05): 29-34 .
    4. 滕薇,刘俊辉,吴金鸿,刘树滔. 酶解—膜分离耦合连续制备抗氧化性小分子透明质酸. 食品与机械. 2023(12): 162-170 .
    5. 李慧凝,张京良,杨艮,江晓路. 酶法制备透明质酸寡糖及其透皮吸收活性研究. 食品工业科技. 2022(06): 77-82 . 本站查看
    6. 石晶,冯云,包杰,樊建茹,徐桂云,范金石. 天然生物质材料的制备、性质与应用(Ⅲ)——医护两用的糖胺聚糖:透明质酸. 日用化学工业. 2022(03): 237-244 .
    7. 郑博文,王斌雅,肖婉玲,孙亚娟,赵炳天,杨成. 基于蛋白质组学的透明质酸寡聚糖抗炎活性研究及验证. 食品与发酵工业. 2022(14): 33-38 .
    8. 张洛瑜,崔云前,郝晨晓,李雅晖. 透明质酸啤酒的研究概况. 食品科技. 2022(08): 43-46 .

    Other cited types(5)

Catalog

    Article Metrics

    Article views (564) PDF downloads (69) Cited by(13)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return